Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Absence of wide-spread mis-splicing in the preclinical phase of a native promoter driven TDP-43 mouse model of ALS

Conference paper

Scaber J. et al, (2016), EUROPEAN JOURNAL OF NEUROLOGY, 23, 797 - 797

Development of LNA gapmer oligonucleotide based therapy for FTD/ALS caused by the C9orf72 repeat expansion

Conference paper

Aoki Y. et al, (2015), NEUROMUSCULAR DISORDERS, 25, S315 - S316

C9orf72 Hexanucleotide Expansion Mutations Alter Calcium Signalling in ALS-FTD Patient iPSC-Derived Motor Neurons

Conference paper

Mutihac R. et al, (2014), ANNALS OF NEUROLOGY, 76, S121 - S121